Indian Pharmacopoeia Commission Launches Seven Nitrosamine Impurity Reference Standards for the First Time
The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, launched seven Indian Pharmacopoeia Nitrosamine Impurities Reference Standards for the first time, at a meeting titled "IP 2026: Perspectives, Suggestions and Way Forward" held with the Central Drugs Laboratory and Central Cosmetics Laboratory in Kolkata, West Bengal. The seven standards are NDMA, NDEA, NEIPA, NDBA, NMPA, NDIPA and NMBA. Nitrosamines are genotoxic and carcinogenic compounds that can arise unintentionally during manufacturing, storage or packaging. The standards will support analytical method validation, quality assurance and self-reliance in critical reference materials.
The Indian Pharmacopoeia Commission is headquartered at Ghaziabad, Uttar Pradesh, and became fully operational as an autonomous body from 1 January 2009 | The Secretary, Ministry of Health and Family Welfare is the ex-officio Chairperson of the IPC | NDMA (N-Nitrosodimethylamine) is classified as a probable human carcinogen